Clinical trial
An Open-Label, Flexible-Dose Trial of the Safety and Efficacy of Geodon in Non-Rapid-Cycling Bipolar II Patients With Major Depression
NCT00237666 is registered in ClinicalTrials.gov with The Medical Research Network as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-Label, Flexible-Dose Trial of the Safety and Efficacy of Geodon in Non-Rapid-Cycling Bipolar II Patients With Major Depression
- Lead sponsor
- The Medical Research Network
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- February 28, 2005
- Completion date
- February 29, 2008
- Enrollment
- 30 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
bipolar ii disorder, major depressive episode